UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 28

Sortiert nach

The effect of carriers’ reproductive choices and pregnancy history on sporadic severe haemophilia: A 20‐year retrospective study through a regional registry

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.308-315

2022

Volltextzugriff (PDF)

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

British journal of haematology, 2022-02, Vol.196 (4), p.871-883

2022

Volltextzugriff (PDF)

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.937-945

2020

Volltextzugriff (PDF)

Addressing the impact of SARS‐CoV‐2 infection in persons with congenital bleeding disorders: The Italian MECCOVID‐19 study

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-07, Vol.27 (4), p.e575-e578

2021

Volltextzugriff (PDF)

Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX-Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective-Prospective Study

Journal of clinical medicine, 2024-03, Vol.13 (5), p.1518

2024

Volltextzugriff (PDF)

Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs

Thrombosis and haemostasis, 2006-10, Vol.96 (4), p.542

2006

Volltextzugriff (PDF)

Anaphylaxis in patients with congenital bleeding disorders and inhibitors

Blood coagulation & fibrinolysis, 2009-06, Vol.20 (4), p.225-229

2009

Volltextzugriff (PDF)

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

Seminars in thrombosis and hemostasis, 2020-10, Vol.46 (7), p.819

2020

Volltextzugriff (PDF)

F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study

Thrombosis and haemostasis, 2017-08, Vol.117 (8), p.1455

2017

Volltextzugriff (PDF)

Severe bleeding in a patient with factor XIII deficiency and COVID‐19

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-01, Vol.27 (1), p.e140-e142

2021

Volltextzugriff (PDF)

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

Thrombosis and haemostasis, 2015-07, Vol.114 (1), p.35

2015

Volltextzugriff (PDF)

Assessment of Hemophilic Arthropathy by Ultrasound: Where Do We Stand?

Seminars in thrombosis and hemostasis, 2016-07, Vol.42 (5), p.541

2016

Volltextzugriff (PDF)

Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients

Seminars in thrombosis and hemostasis, 2017-02, Vol.43 (1), p.69

2017

Volltextzugriff (PDF)

Clinical efficacy and determinants of response to treatment with desmopressin in mild hemophilia a

Seminars in thrombosis and hemostasis, 2013-10, Vol.39 (7), p.732

2013

Volltextzugriff (PDF)

A Web Site to Improve Management of Patients with Inherited Bleeding Disorders in the Emergency Department: Results at 2 Years

Seminars in thrombosis and hemostasis, 2016-07, Vol.42 (5), p.589

2016

Volltextzugriff (PDF)

Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Blood transfusion = Trasfusione del sangue, 2020-03, Vol.18 (2), p.143-151

2020

Volltextzugriff (PDF)

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors

Journal of thrombosis and haemostasis, 2009-11, Vol.7 (11), p.1809-1815

2009

Volltextzugriff (PDF)

Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres

Seminars in thrombosis and hemostasis, 2016-02, Vol.42 (1), p.36

2016

Volltextzugriff (PDF)

Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

Blood transfusion = Trasfusione del sangue, 2015-07, Vol.13 (3), p.498-513

2015

Volltextzugriff (PDF)

Hemophilia and cancer: A new challenge for hemophilia centers

Cancer treatment reviews, 2009-06, Vol.35 (4), p.374-377

2009

Volltextzugriff (PDF)

The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

European journal of haematology, 2016-07, Vol.97 (S83), p.3-18

2016

Volltextzugriff (PDF)

Epidemiological data and treatment strategies in children with severe haemophilia in Italy

Annali dell'Istituto superiore di sanità, 2020-01, Vol.56 (4)

2020

Volltextzugriff (PDF)

The first T eam H aemophilia E ducation meeting, 2015, A msterdam, The N etherlands

European journal of haematology, 2016-07, Vol.97 (S83), p.3-18

2016

Volltextzugriff (PDF)

Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy

Haemophilia : the official journal of the World Federation of Hemophilia, 2014-07, Vol.20 (4), p.e243-e250

2014

Volltextzugriff (PDF)

Secondary prophylaxis in adolescent and adult haemophiliacs

Blood transfusion = Trasfusione del sangue, 2008-09, Vol.6 Suppl 2 (Suppl 2), p.s17-s20

2008

Volltextzugriff (PDF)

1 – 25 von 28

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(27)
Berichte
(1)

Sprache

Englisch
(28)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The effect of carriers’ reproductive choices and pregnancy history on sporadic severe haemophilia: A 20‐year retrospective study through a regional registry

Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres

Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Addressing the impact of SARS‐CoV‐2 infection in persons with congenital bleeding disorders: The Italian MECCOVID‐19 study

Six-Year, Real-World Use of Prophylaxis with Recombinant Factor IX-Albumin Fusion Protein (rIX-FP) in Persons with Hemophilia B: A Single-Center Retrospective-Prospective Study

Experience of secondary prophylaxis in 20 adolescent and adult Italian hemophiliacs

Anaphylaxis in patients with congenital bleeding disorders and inhibitors

Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders

F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study

Severe bleeding in a patient with factor XIII deficiency and COVID‐19

Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study

Assessment of Hemophilic Arthropathy by Ultrasound: Where Do We Stand?

Blood Group O Protects against Inhibitor Development in Severe Hemophilia A Patients

Clinical efficacy and determinants of response to treatment with desmopressin in mild hemophilia a

A Web Site to Improve Management of Patients with Inherited Bleeding Disorders in the Emergency Department: Results at 2 Years

Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET

Factor VIII gene (F8) mutations as predictors of outcome in immune tolerance induction of hemophilia A patients with high‐responding inhibitors

Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres

Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management

Hemophilia and cancer: A new challenge for hemophilia centers

The first Team Haemophilia Education meeting, 2015, Amsterdam, The Netherlands

Epidemiological data and treatment strategies in children with severe haemophilia in Italy

The first T eam H aemophilia E ducation meeting, 2015, A msterdam, The N etherlands

Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy

Secondary prophylaxis in adolescent and adult haemophiliacs

Suchergebnisse filtern